Inhibition of telomerase activity using a dominant negative construct of hTERT in prostate cancer cell lines
Guo, C.; Hamad, N.; Geverd, D.; Liao, R.P.; Counter, C.M.; Price, D.T.
Journal of Urology 163(4 Suppl): 101
2000
ISSN/ISBN: 0022-5347 Accession: 035143868
PDF emailed within 1 workday: $29.90
Related References
Delhommeau, Fçois.; Thierry, A.; Feneux, Dèle.; Lauret, E.; Leclercq, E.; Courtier, M.Hélène.; Sainteny, Fçoise.; Vainchenker, W.; Bennaceur-Griscelli, A. 2002: Telomere dysfunction and telomerase reactivation in human leukemia cell lines after telomerase inhibition by the expression of a dominant-negative hTERT mutant Oncogene 21(54): 8262-8271Rao, Y.; Xiong, W.; Liu, H.; Jia, C.; Zhang, H.; Cui, Z.; Zhang, Y.; Cui, J. 2016: Inhibition of telomerase activity by dominant-negative hTERT retards the growth of breast cancer cells Breast Cancer 23(2): 216-223
Ramachandran, C.; Fonseca, H.B.; Jhabvala, P.; Melnick, S.J.; Escalon, E. 2001: Inhibition of Human Telomerase Reverse Transcritpase (hTERT) and Telomerase Activity by Curcumin in Human Mammary Epithelial and Breast Carcinoma Cell Lines Thescientificworldjournal 1: 109
Fu, X.-H.; Zhang, J.-S.; Zhang, N.; Zhang, Y.-D. 2005: Combination of telomerase antisense oligonucleotides simultaneously targeting hTR and hTERT produces synergism of inhibition of telomerase activity and growth in human colon cancer cell line World Journal of Gastroenterology 11(6): 785-790
Saretzki, G.; Petersen, S.; Petersen, I.; Kölble, K.; von Zglinicki, T. 2002: HTERT gene dosage correlates with telomerase activity in human lung cancer cell lines Cancer Letters 176(1): 81-91
Jung, J.; Park, Y.; Jong, H.; Im, S.; Song, Y.; Kim, W.; Bang, Y. 2016: The activity of CKD601, telomerase inhibitor, against gastric cancer cell lines and resistance mechanism, which is associated with hTERT expression and ALT Journal of Clinical Oncology 24(18_Suppl): 13126-13126
Zhdanov, D.D.; Vasina, D.A.; Orlova, V.S.; Orlova, E.V.; Grishin, D.V.; Gladilina, Y.A.; Pokrovskaya, M.V.; Aleksandrova, S.S.; Sokolov, N.N. 2017: Induction of apoptotic endonuclease EndoG with DNA-damaging agents initiates alternative splicing of telomerase catalytic subunit hTERT and inhibition of telomerase activity hTERT in human CD4+ and CD8+ T-lymphocytes Biomeditsinskaia Khimiia 63(4): 296-305
Killedar, A.; Stutz, M.D.; Sobinoff, A.P.; Tomlinson, C.G.; Bryan, T.M.; Beesley, J.; Chenevix-Trench, G.; Reddel, R.R.; Pickett, H.A. 2015: A Common Cancer Risk-Associated Allele in the hTERT Locus Encodes a Dominant Negative Inhibitor of Telomerase Plos Genetics 11(6): E1005286
Brambilla, C.; Folini, M.; Gandellini, P.; Daprai, L.; Daidone, M.G.; Zaffaroni, N. 2004: Oligomer-mediated modulation of hTERT alternative splicing induces telomerase inhibition and cell growth decline in human prostate cancer cells Cellular and Molecular Life Sciences: Cmls 61(14): 1764-1774
Gao, X.-d.; Chen, Y.-r. 2007: Inhibition of telomerase with hTERT antisense enhances TNF-alpha-induced apoptosis in prostate cancer cells PC3 Zhonghua Nan Ke Xue 13(8): 723-726
Huang, K.-Z.; Nie, D.-N.; Yin, S.-M.; Li, Y.-Q.; Xie, S.-F.; Ma, L.-P.; Wang, X.-J.; Wu, Y.-D. 2011: Cyclin D1, hTERT expression and telomerase activity in HL-60 and HL-60A cell lines and their significance Zhongguo Shi Yan Xue Ye Xue Za Zhi 19(4): 911-915
Deeb, D.; Gao, X.; Liu, Y.; Kim, S.-H.; Pindolia, K.R.; Arbab, A.S.; Gautam, S.C. 2012: Inhibition of cell proliferation and induction of apoptosis by oleanane triterpenoid (CDDO-Me) in pancreatic cancer cells is associated with the suppression of hTERT gene expression and its telomerase activity Biochemical and Biophysical Research Communications 422(4): 561-567
Rahman, R.; Mo, L.; Cui, W. 2006: Telomerase with mutated catalytic motifs has dominant negative effects on telomerase activity and inhibits cell growth Biochemical and Biophysical Research Communications 350(3): 796-802
Pizzimenti, S.; Briatore, F.; Laurora, S.; Toaldo, C.; Maggio, M.; De Grandi, M.; Meaglia, L.; Menegatti, E.; Giglioni, B.; Dianzani, M.U.; Barrera, G. 2006: 4-Hydroxynonenal inhibits telomerase activity and hTERT expression in human leukemic cell lines Free Radical Biology and Medicine 40(9): 1578-1591
Metzger, R.; Vallbohmer, D.; Müller-Tidow, C.; Higashi, H.; Bollschweiler, E.; Warnecke-Eberz, U.; Brabender, J.; Baldus, S.E.; Xi, H.; Berdel, W.E.; Serve, H.; Hoelscher, A.H.; Schneider, P.M. 2009: Increased human telomerase reverse transcriptase (hTERT) mRNA expression but not telomerase activity is related to survival in curatively resected non-small cell lung cancer Anticancer Research 29(4): 1157-1162
Xu, T.; Rao, Y.; Zhu, W.; Guo, F. 2006: Inhibition of cell growth and telomerase activity in osteosarcoma cells by DN-hTERT Journal of Huazhong University of Science and Technology. Medical Sciences 26(5): 601-603
Sun, L.-b.; Li, C.-r.; Wen, J.-m.; Wang, G.-b.; Zhang, M.; Yang, J.; Li, R.-x. 2004: Antisense hTERT inhibits gene expression and functional activity of telomerase in leukemia cell lines Zhonghua Bing Li Xue Za Zhi 33(5): 454-457
Kageyama, Y.; Kamata, S.; Yonese, J.; Oshima, H. 1997: Telomere length and telomerase activity in bladder and prostate cancer cell lines International Journal of Urology: Official Journal of the Japanese Urological Association 4(4): 407-410
DE Holanda, L.S.; Mesquita, F.P.; DE Moraes-Filho, M.O.; DE Moraes, M.E.A.; Montenegro, R.C.; DE Sousa Portilho, A.J.; Moreira-Nunes, C.A. 2019: Characterization of Telomerase (hTERT) in Solid and Hematopoietic Cancer Cell Lines Reveals Different Expression Patterns Anticancer Research 39(9): 4743-4748
Abbas, A.; Hall, J.A.; Patterson, W.L.; Ho, E.; Hsu, A.; Al-Mulla, F.; Georgel, P.T. 2016: Sulforaphane modulates telomerase activity via epigenetic regulation in prostate cancer cell lines Biochemistry and Cell Biology 94(1): 71-81